.
1. Jennett
B, Teasdale G. Management of head injuries. Philadelphia: FA Davies, 1981.
..
2. Jennett B, Bond M. Assessment of outcome after severe
brain damage. Lancet 1975;1: 480-4.
..
3. Alderson P, Roberts I. Corticosteroids in acute traumatic
brain injury: systematic review of randomised controlled trials. BMJ 1997;314:1855-9.
..
4. Bracken MB, Shepard MJ, Collins WF, et al. A randomised
controlled trial of methylprednisolone or naloxone in the treatment of acute
spinal cord injury. N Eng J Med 1990;322:1405-11.
..
5. Otani K, Abe H, Kadoya S, et al. Beneficial effect
of methylprednisolone sodium succinate in the treatment of acute spinal
cord injury (translation of Japanese). Sekitsui Sekizui J 1994;7:633-47.
..
6. Bracken MB, Shepard MJ, Holford TR, et al. Administration
of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours
in the treatment of acute spinal cord injury. Results of the Third National
Acute Spinal Cord Injury Randomized Controlled Trial. National Acute
Spinal Cord Injury Study. JAMA 1997;277:1597-604
..
7. Demopoulos HB, Flamm ES, Seligman ML. Further studies
on free radical pathology in the major central nervous system disorders:
effects of very high doses of methylprednisolone on the functional outcome,
morphology, and chemistry of experimental spinal cord impact injury. Can
J Physiol Pharmacol 1982;60:1415-24.
..
8. Anderson DK, Saunders RD, Demediuk P. Lipid hydrolysis
and peroxidation in injured spinal cord: partial protection with methylprednisolone
or vitamin E and selenium. Central Nervous System Trauma 1985;2:257-67.
..
9. Braughler JM, Hall ED, Means ED, et al. Evaluation of
an intensive methylprednisolone sodium succinate dosing regimen in experimental
spinal cord injury. J Neurosurg 1987; 67: 102-5.
..
10. Hall ED. High dose glucocorticoid treatment improves
neurological recovery in head-injured mice. J Neurosurg 1985;62:882-7.
..
11. Hall ED. The neuroprotective pharmacology of methylprednisolone.
J. Neurosurg 1992;76:13-22.
..
12. Gaab MR, Trost HA, Alcantara A, et al. Ultrahigh dexamethasone
in acute brain injury. Results from a prospective randomised double-blind
multi-centre trial. Zentralblatt für Neurochirurgie 1994;55:135-43.
..
13. Collins R, Doll R, Peto R. Ethics of clinical trials.
In: Williams C, ed. Introducing New Treatments for Cancer. Chichester: John
Wiley and Sons Ltd, 1991.
..
14. Ewan PW. Treatment of anaphylactic reactions.
Prescribers Journal 1997;37:125-32.
..
15. Peto R, Pike MC, Armitage P, et al. Design and analysis
of randomised clinical trials requiring prolonged observation of each patient.
1. Introduction and design. Br J Cancer 1976;34:585-612.
.. |